Chiasma Inc.

www.chiasmapharma.com

Now Chiasma Israel (an Amryt Pharma company)

High-Tech Company

Acquired by Amryt Pharma

TAGS

Biotechnology, Drug Delivery, medication, Therapeutics

General Data

Sector	Life Sciences
Sub-Sector	Biotechnology

TECHNOLOGY

Chiasma’s proprietary Transient Permeability Enhancer (TPE®) technology platform is designed to enable the development of oral forms of medications that are currently only available as injections. TPE aims to protect drug molecules from dig...(Unlock More)...

CONTACT INFO

Personal Contact Information

Blog

Expand / Collapse All

	MANAGEMENT

Key Executive

	BOARD

Board

	FINANCIAL ROUNDS

Round

Date

Stage

Amount

Valuation

Fifth Round

Feb. 27, 2015

R&D

$70m

$146m

General Info

Angel Company & Title
E-mail
Website
No. of Current Portfolio Companies
Remarks

Business Description

Description
Angel Activity

Investment Data

Managed Capital
Capital Remarks
Capital Available

Preferences

Maximum investments
Minimum investments
Type of Financing
Stage Preferences
Phase Preferences
Industry Preferences

	SECTOR SEGMENTATION (By Number Of Companies)

Current Israeli Clients (#)

	Deals Underwritten (#)

	Deals Legally Advised (#)

	Current Positions

	Previous Positions

	Background

	Education

	Specialties

Last Updated: Feb 13, 2023